Table 1

Characteristics of patients and GMP in NSCLC

No. of patients (%)No. of patients (%) according to GMP status
GMP- negativeGMP- positiveP
All patients236 (100%)176 (74.6%)60 (25.4%)
Age (mean ±SD)62.4± 9.762.7± 9.661.7± 10.00.489
Gender
 Male170 (72.0%)128 (75.3%)42 (24.7%)0.740
 Female66 (28.0%)48 (72.7%)18 (27.3%)
Performance status (PS)
 0206 (87.3%)156 (75.7%)50 (24.3%)0.485
 128 (11.9%)19 (67.9%)9 (32.1%)
 22 (0.8%)1 (50.9%)1 (50.0%)
Histologic type
 Sq85 (36.0%)65 (76.5%)20 (23.5%)0.529 (Sq vs. Ad)
 Ad130 (55.1%)94 (72.3%)36 (27.7%)
 Large cell carcinoma13 (5.5%)12 (92.3%)1 (7.7%)
 Others8 (3.4%)5 (62.5%)3 (37.5%)
p-stage
 I138 (58.5%)101 (73.2%)37 (26.8%)0.265 (for all p-stage)
 II26 (11.0%)17 (65.4%)9 (34.6%)
 IIIA72 (30.5%)58 (80.6%)14 (19.4%)